WA
COCP icon

Wasatch Advisors’s Cocrystal Pharma COCP Stock Holding History

Wasatch Advisors’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-149,958
Closed -$892K – 241
2019
Q4 		$892K Buy
149,958
+53,897
+56% +$538K 0.01% 238
2019
Q3 		$2.35M Hold
96,061
– – 0.02% 227
2019
Q2 		$2.71M Buy
96,061
+4,936
+5% +$147K 0.03% 213
2019
Q1 		$2.78M Buy
91,125
+59,176
+185% +$2.17M 0.03% 211
2018
Q4 		$1.38M Sell
31,949
-6,875
-18% -$227K 0.02% 218
2018
Q3 		$1.17M Sell
38,824
-3,336
-8% -$149K 0.01% 229
2018
Q2 		$1.85M Buy
+42,160
New +$1.56M 0.02% 227

Other funds holding COCP

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
EU
Emory University Atlanta, Georgia $160M AUM 8.57% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

Wasatch Advisors's COCP Position: Q1 2020 in Review

Wasatch Advisors sold out of Cocrystal Pharma (COCP) in Q1 2020, closing a stake of 149,958 shares — an estimated $892K sold.

Wasatch Advisors first reported a position in COCP in Q2 2018 and held it in 7 quarters. The position peaked at $2.78M in Q1 2019. 24 funds tracked by Wall St. Rank hold COCP as of Q1 2020.

  • Wasatch Advisors reported no remaining Cocrystal Pharma position as of Q1 2020 after selling out during the quarter.
  • Wasatch Advisors sold 149,958 Cocrystal Pharma shares in Q1 2020, an estimated $892K.
  • Wasatch Advisors first reported a position in Cocrystal Pharma in Q2 2018 and held it in 7 quarters.
  • Wasatch Advisors's Cocrystal Pharma position peaked at $2.78M in Q1 2019.
  • 24 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q1 2020.

Based on Wasatch Advisors's 13F filing for Q1 2020, filed 8 May 2020.